can nurse practitioners prescribe glp 1 The New Weight Management Meds GLP-1RAs in Neuroendocrine Tumors: The

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

The day you take a GLP-1 injection matters less than consistency, meal timing, and individual biomarker response

GLP-1 users are spending less on indulgent snacks like chips and cookies, while buying more yogurt, fruit, and vegetables

Checkout the full interview on...

Users gravitate toward nutrient-dense foodsnutrition -bars, yoghurts, fresh produceaiming to maintain essential nutrient intake while eating much less

Yesterday, the World Health Organization published a guideline in JAMA on the use and indications of #GLP-1 therapies for the management of #obesity in adults